Similar articles

• Graft-versus-leukaemia after bone marrow transplantation.

  Barret AJ. Barret AJ. Pediatr Med Chir. 1991 Jan-Feb;13(1):9-13. Pediatr Med Chir. 1991. PMID: 2052462 Review. No abstract available.
• Graft-versus-leukemia and graft-versus-lymphoma effects of allogeneic bone marrow transplantation and of allogeneic donor leukocyte transfusions.

  Vandenberghe P, Boogaerts MA. Vandenberghe P, et al. Ann Hematol. 1995 Nov;71(5):209-17. doi: 10.1007/BF01744370. Ann Hematol. 1995. PMID: 7492623 Review. No abstract available.
• The immunogenetics of chronic graft versus host disease and its relevance for the graft versus leukemia effect.

  van Rood JJ, Goulmy E, van Leeuwen A. van Rood JJ, et al. Prog Clin Biol Res. 1987;244:433-8. Prog Clin Biol Res. 1987. PMID: 3310005 No abstract available.
• Autoreactive T cells isolated during graft-versus-host disease (GvHD) may be involved in the generation of an anti-leukemic effect after bone marrow transplantation (BMT).

  Schneider EM, Dörre S, Wernet P. Schneider EM, et al. Transplant Proc. 1989 Feb;21(1 Pt 3):3018-21. Transplant Proc. 1989. PMID: 2650416 No abstract available.
• Manipulation of graft-versus-host disease for a graft-versus-leukemia effect after allogeneic bone marrow transplantation in AKR mice with spontaneous leukemia/lymphoma.

  Truitt RL, Shih CC, LeFever AV. Truitt RL, et al. Transplantation. 1986 Mar;41(3):301-10. doi: 10.1097/00007890-198603000-00005. Transplantation. 1986. PMID: 3513389